MetaCap

Trupanion Inc. (TRUP)

NASDAQ: TRUPHealth CareMedical SpecialitiesUSD

35.56-0.31 (-0.86%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

TRUP stock chart

Technical analysis

Key statistics

All statistics
52-week range
21.16 – 38.87
Day range
35.25 – 36.99
Volume / Avg
495.39K / 443.82K
Beta
—

52-week range

$21.16$38.87

TRUP stock today

Shares of Trupanion (TRUP) finished lower on Nov 20 at $35.56, a drop of 0.86% or $0.31 per share, versus the S&P 500's 3.70% decline. Shares are 8.5% below their 52-week high of $38.87, set on Dec 22, 2025 and 68.1% above the 52-week low of $21.16, near the top of the past year's range. TRUP is down 4.8% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 0.9%.

At 58.3x trailing earnings, Trupanion trades above the peer-group median of 30.9x. Its forward P/E of 8.1x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year.

Summary generated from market data by MetaCap's automated system. Methodology

About Trupanion

Company profile

Trupanion, Inc., together with its subsidiaries, provides medical insurance for cats and dogs on subscription basis in the United States, Canada, and Continental Europe. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.

Industry
Medical Specialities
CEO
Ms. Margaret Rosemary Maria Tooth
Headquarters
Seattle, WA
Employees
1,121

Financial highlights

Full financials

In fiscal 2025, Trupanion generated $1.44 billion in revenue, up 11.9% from fiscal 2024, its 13th consecutive year of revenue growth. Net income was $19.4 million, for a net margin of 1.4% versus a median of -4.0% in the prior 5 years. Gross margin was 16.1% (up from 13.9%) and operating margin 1.0%.

Trupanion annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue$1.44B$1.29B$1.11B$905.18M$698.99M
Growth+11.95%+15.97%+22.47%+29.50%+39.23%
Net income$19.43M$-9.63M$-44.69M$-44.67M$-35.53M
EPS (diluted)$0.45$-0.23$-1.08$-1.10$-0.89

Analyst forecast

Forecast

Consensus (6 analysts)

buy

Avg. price target

$36.75+3.35%

  • Strong buy 0
  • Buy 2
  • Hold 4
  • Sell 0
  • Strong sell 0

Target range

Low $32.00High $48.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Nov 5, 2026
EPS actual vs est.
$0.21 vs $0.16
Surprise
+31.25%

TRUP news

All TRUP news

Trupanion peers

Health Care sector
TRUP peer companies
CompanyPrice% ChgMarket capCompare
PSNLPersonalis Inc.14.27-3.06%$1.55Bvs TRUP
LMRILumexa Imaging Holdings Inc.14.26+1.42%$1.37Bvs TRUP
ALHCAlignment Healthcare Inc.6.37-2.00%$1.33Bvs TRUP
FTREFortrea Holdings Inc.18.55-7.94%$1.79Bvs TRUP
CLOVClover Health Investments Corp. Class A3.73-1.06%$2.00Bvs TRUP
VCYTVeracyte Inc.25.13+0.36%$2.03Bvs TRUP
FRNMFreenome Inc.9.36-5.69%$1.04Bvs TRUP
CSTLCastle Biosciences Inc.32.86-1.63%$1.01Bvs TRUP

Indexes, lists and sector

Trupanion stock FAQ

What is Trupanion's stock price today?

TRUP last traded at $35.56 as of Nov 20, 4:00 PM EST, down 0.86% on the day. Prices are delayed at least 15 minutes.

What is TRUP's P/E ratio?

TRUP trades at a trailing P/E ratio of 58.30 and a forward P/E of 8.14, compared with a median of 30.9 for its closest peers.

Who is Trupanion's CEO?

Ms. Margaret Rosemary Maria Tooth is the chief executive officer of Trupanion Inc., which has about 1,121 employees.

What is the TRUP 52-week high?

The 52-week high for TRUP is $38.87 and the 52-week low is $21.16. The stock is currently 8.5% below its high.

Compare TRUP